Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
65 hedge funds and large institutions have $29.8M invested in Molecular Templates, Inc. in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 27 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less funds holding
Funds holding: 77 → 65 (-12)
30% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 20
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
76% less capital invested
Capital invested by funds: $125M → $29.8M (-$94.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$1.48M |
| 2 |
Millennium Management
New York
|
+$1.08M |
| 3 |
Renaissance Technologies
New York
|
+$714K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$312K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$283K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.61M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.08M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.06M |
| 4 |
State Street
Boston,
Massachusetts
|
-$778K |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$769K |
MTEM Hedge Fund Activity: Q2 2022 in Review
65 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q2 2022, worth a combined $29.8M — down 76% from $125M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of MTEM and 17 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 14 added.
The largest buyer was BVF Inc, adding an estimated $1.48M. The largest seller was BlackRock, cutting an estimated $2.61M.
- 65 institutional investors held Molecular Templates, Inc. (MTEM) as of Q2 2022, down from 77 in Q1 2022.
- Funds reported $29.8M of Molecular Templates, Inc. stock for Q2 2022, down 76% quarter-over-quarter.
- 17 funds opened new Molecular Templates, Inc. positions in Q2 2022 and 27 closed out, a net change of -10 holders.
- The largest Molecular Templates, Inc. buyer in Q2 2022 was BVF Inc, an estimated $1.48M added.
- The largest Molecular Templates, Inc. seller in Q2 2022 was BlackRock, an estimated $2.61M sold.
Based on aggregated 13F filings for Q2 2022.